The Hamilton General Hospital is a major teaching hospital in Downtown Hamilton, Ontario, Canada, located at the intersection of Barton Street East and Victoria Avenue North. It is operated by Hamilton Health Sciences and is formally affiliated with the Michael G. DeGroote School of Medicine at McMaster University.

During the past decade, Hamilton General Hospital conducted 132 clinical trials. In the 10-year time frame, 132 clinical trials started and 26 clinical trials were completed, i.e. on average, 19.7% percent of trials that started reached the finish line to date. In the past 5 years, 55 clinical trials started and 17 clinical trials were completed. i.e. 30.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hamilton General Hospital" #1 sponsor was "Population Health Research Institute" with 42 trials, followed by "McMaster University" with 36 trials sponsored, "Hamilton Health Sciences Corporation" with 29 trials sponsored, "Unity Health Toronto" with 9 trials sponsored and "Ottawa Hospital Research Institute" with 9 trials sponsored. Other sponsors include 86 different institutions and companies that sponsored additional 64 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hamilton General Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 37 trials as a collaborator, "Hamilton Health Sciences Corporation" with 25 trials as a collaborator, "McMaster University" with 12 trials as a collaborator, "Heart and Stroke Foundation of Canada" with 8 trials as a collaborator and "The Physicians' Services Incorporated Foundation" with 8 trials as a collaborator. Other collaborators include 225 different institutions and companies that were collaborators in the rest 174 trials.

According to Clinical.Site data, the most researched conditions in "Hamilton General Hospital" are "Atrial Fibrillation" (18 trials), "Venous Thromboembolism" (11 trials), "Deep Vein Thrombosis" (10 trials), "Coronary Artery Disease" (7 trials) and "Stroke" (7 trials). Many other conditions were trialed in "Hamilton General Hospital" in a lesser frequency.

Most popular intervention types in "Hamilton General Hospital" are "Drug" (80 trials), "Other" (40 trials), "Device" (39 trials), "Procedure" (36 trials) and "Behavioral" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Aspirin" (6 trials), "Apixaban" (5 trials), "Rivaroxaban" (5 trials) and "Tranexamic Acid" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hamilton General Hospital" are 213 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are 61 active trials in "Hamilton General Hospital". 5 are not yet recruiting, 31 are recruiting, 23 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 112 completed trials in Hamilton General Hospital, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Hamilton General Hospital, 1 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 64 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 16 trials, and there were also 71 trials that are defined as “Not Applicable".